Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/ANNEXON-INC-110038737/attualita/Annexon-riferisce-i-risultati-della-Fase-1-di-ANX1502-il-suo-inibitore-orale-di-piccole-molecole-de-45615996/?utm_source=whatsapp&utm_medium=social&utm_campaign=share